6943-69-7 Usage
Uses
Used in Synthetic Chemistry Research:
5-Bromo-4-methoxy-2-nitroaniline is utilized as a key intermediate in the synthesis of various organic compounds. Its unique structure and functional groups make it a valuable building block for the development of new molecules with potential applications in various fields, such as pharmaceuticals, agrochemicals, and materials science.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-Bromo-4-methoxy-2-nitroaniline is employed as a precursor for the synthesis of active pharmaceutical ingredients (APIs). Its versatile chemical structure allows for the creation of novel drug candidates with potential therapeutic effects against various diseases and conditions.
Used in Agrochemical Industry:
5-Bromo-4-methoxy-2-nitroaniline is also used as a starting material in the synthesis of agrochemicals, such as pesticides and herbicides. Its unique properties enable the development of new compounds with improved efficacy and selectivity, contributing to more sustainable and environmentally friendly agricultural practices.
Used in Materials Science:
In the field of materials science, 5-Bromo-4-methoxy-2-nitroaniline is explored for its potential use in the development of advanced materials with specific properties, such as high thermal stability, electrical conductivity, or optical characteristics. Its incorporation into polymers, coatings, or other materials can lead to innovative applications in various industries.
Overall, 5-Bromo-4-methoxy-2-nitroaniline is a versatile and valuable compound in the realm of synthetic chemistry, with a wide range of applications across different industries. Its unique structure and properties make it an essential component in the development of new and improved products, from pharmaceuticals to advanced materials.
Check Digit Verification of cas no
The CAS Registry Mumber 6943-69-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,9,4 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 6943-69:
(6*6)+(5*9)+(4*4)+(3*3)+(2*6)+(1*9)=127
127 % 10 = 7
So 6943-69-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H7BrN2O3/c1-13-7-3-6(10(11)12)5(9)2-4(7)8/h2-3H,9H2,1H3
6943-69-7Relevant academic research and scientific papers
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
-
Paragraph 0620; 0713, (2020/08/22)
Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
Investigation of novel 7,8-disubstituted-5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-ones as potent Chk1 inhibitors
Hasvold, Lisa A.,Wang, Le,Przytulinska, Magdalena,Xiao, Zhan,Chen, Zehan,Gu, Wen-Zhen,Merta, Philip J.,Xue, John,Kovar, Peter,Zhang, Haiying,Park, Chang,Sowin, Thomas J.,Rosenberg, Saul H.,Lin, Nan-Horng
, p. 2311 - 2315 (2008/09/21)
The synthesis and structure-activity relationships (SAR) of Chk1 inhibitors based on a 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one core are described. Specifically, an exploration of the 7 and 8 positions on this previously disclosed core afforded compounds with improved enzymatic and cellular potency.
HETEROCYCLIC KINASE INHIBITORS
-
Page 145, (2010/02/08)
Compounds having the formula (I) are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
Heterocyclic Systems Containing Bridgehead Nitrogen Atom: Part LIV - Synthesis of Thiazolobenzimidazol-3-(2H)-ones
Bindal, Varinder,Jain, Kiran,Handa, R. N.,Pujari, H. K.
, p. 807 - 811 (2007/10/02)
3-Bromo-4-methoxyacetanilide (V) on nitration with fuming nitric acid in the presence of acetic anhydride gives 3-bromo-4-methoxy-6-nitroacetanilide (VI) which on hydrolysis and subsequent reduction of the nitroaniline (IX) followed by the treatment of th
